AGP Executive Report
Last update: 8 hours agoMeasles Alert: US CDC reports 2,318 measles cases in 2026—surpassing last year’s total and the highest level since 1991—prompting renewed focus on MMR protection for travelers and World Cup returnees. UK Workforce & Training: The Royal College of Physicians says doctor burnout remains widespread despite “small green shoots” in the GMC training survey, and calls for a workforce retention strategy plus safer, more inclusive training environments. NHS Policy Push: RCP also urges the new UK government to prioritize health inequalities, prevention, social care reform, and long-term NHS workforce planning. Healthcare Access & Capacity (India): Aster DM Quality Care plans Rs 1,315 crore investment in Karnataka to expand hospitals and beds after its merger-driven network buildout. Drug Development: Celcuity’s REVTORPYK (gedatolisib) gains FDA approval for HR+/HER2−, PIK3CA wild-type breast cancer in combination regimens, with further sNDA plans for PIK3CA-mutant disease. Clinical Safety Signal: The TREASURE trial finds adding consolidative thoracic radiotherapy to atezolizumab increases severe/fatal toxicity without survival benefit in extensive-stage small cell lung cancer. Public Health Food Safety: FDA recalls 1.59 million dozen eggs over possible salmonella contamination, with no illnesses reported yet.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
